Association of hypogonadism with vitamin D status: the European Male Ageing Study.

OBJECTIVE Interrelationships between hormones of the hypothalamic-pituitary-testicular (HPT) axis, hypogonadism, vitamin D and seasonality remain poorly defined. We investigated whether HPT axis hormones and hypogonadism are associated with serum levels of 25-hydroxyvitamin D (25(OH)D) in men. DESIGN AND METHODS Cross-sectional survey of 3369 community-dwelling men aged 40-79 years in eight European centres. Testosterone (T), oestradiol (E(2)) and dihydrotestosterone were measured by gas chromatography-mass spectrometry; LH, FSH, sex hormone binding globulin (SHBG), 25(OH)D and parathyroid hormone by immunoassay. Free T was calculated from total T, SHBG and albumin. Gonadal status was categorised as eugonadal (normal T/LH), secondary (low T, low/normal LH), primary (low T, elevated LH) and compensated (normal T, elevated LH) hypogonadism. Associations of HPT axis hormones with 25(OH)D were examined using linear regression and hypogonadism with vitamin D using multinomial logistic regression. RESULTS In univariate analyses, free T levels were lower (P=0.02) and E(2) and LH levels were higher (P<0.05) in men with vitamin D deficiency (25(OH)D <50 nmol/l). 25(OH)D was positively associated with total and free T and negatively with E(2) and LH in age- and centre-adjusted linear regressions. After adjusting for health and lifestyle factors, no significant associations were observed between 25(OH)D and individual hormones of the HPT axis. However, vitamin D deficiency was significantly associated with compensated (relative risk ratio (RRR)=1.52, P=0.03) and secondary hypogonadism (RRR=1.16, P=0.05). Seasonal variation was only observed for 25(OH)D (P<0.001). CONCLUSIONS Secondary and compensated hypogonadism were associated with vitamin D deficiency and the clinical significance of this relationship warrants further investigation.

[1]  J. Manson,et al.  The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. , 2011, Journal of the American Dietetic Association.

[2]  S. Pilz,et al.  Effect of vitamin D supplementation on testosterone levels in men. , 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[3]  G. Strapazzon,et al.  Testiculopathy and vitamin D insufficiency , 2010, The Lancet.

[4]  Benjamin R. Szwejkowski,et al.  Vitamin D and cardiovascular prevention. , 2010, Cardiovascular therapeutics.

[5]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[6]  H. Leffers,et al.  Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. , 2010, Human reproduction.

[7]  A. Silman,et al.  Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. , 2010, The Journal of clinical endocrinology and metabolism.

[8]  W. März,et al.  Association of vitamin D status with serum androgen levels in men , 2009, Clinical endocrinology.

[9]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[10]  A. Silman,et al.  Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. , 2009, European journal of endocrinology.

[11]  A. Silman,et al.  The European Male Ageing Study (EMAS): design, methods and recruitment. , 2009, International journal of andrology.

[12]  A. Silman,et al.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. , 2008, The Journal of clinical endocrinology and metabolism.

[13]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[14]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[15]  M. Dowsett,et al.  Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.

[16]  T. Travison,et al.  Prevalence of symptomatic androgen deficiency in men. , 2007, The Journal of clinical endocrinology and metabolism.

[17]  A. Nangia,et al.  Testicular maturation arrest to testis cancer: spectrum of expression of the vitamin D receptor and vitamin D treatment in vitro. , 2007, The Journal of urology.

[18]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[19]  P. Bélanger,et al.  Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[21]  S. Cummings,et al.  Testosterone and estradiol among older men. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  J. Reginster,et al.  No major month to month variation in free testosterone levels in aging males. Minor impact on the biological diagnosis of ‘andropause’ , 2005, Psychoneuroendocrinology.

[23]  J. McGrath,et al.  Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.

[24]  A. Vermeulen Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. , 2005, Journal of endocrinological investigation.

[25]  Steven A. Smith,et al.  Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.

[26]  P. Lips Which circulating level of 25-hydroxyvitamin D is appropriate? , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  E. Barrett-Connor,et al.  Seasonal variation of testosterone and waist to hip ratio in men: the Tromsø study. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[29]  T. Moriwake,et al.  Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. , 2000, Endocrinology.

[30]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  H. DeLuca,et al.  Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[32]  R. Perez-Fernandez,et al.  Vitamin D receptor gene expression in human pituitary gland. , 1996, Life sciences.

[33]  A. Jette,et al.  The Physical Activity Scale for the Elderly (PASE): development and evaluation. , 1993, Journal of clinical epidemiology.

[34]  J. Mckinlay,et al.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. , 1991, The Journal of clinical endocrinology and metabolism.

[35]  D B Reuben,et al.  An Objective Measure of Physical Function of Elderly Outpatients , 1990, Journal of the American Geriatrics Society.

[36]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.